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bstract
im  of  the  study:  The anticancer activity of red cabbage (RC) and the underlying mechanisms against human cervical and hepatocarcinoma cancer
ells were explored in this study.
aterials  and  methods:  The cytotoxic activity of RC extract was assessed using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
ulfophenyl)-2H-tetrazolium (MTS) cytotoxicity assay. ELISA was used to detect the level of anticancer cytokines, TNF and IFN, in the culture
upernatants of cancer cells. Apoptotic cells were investigated by flow cytometry. The levels of apoptotic genes (Bax, BCL-2, Capsases 7–9), cell
ycle regulatory genes (cyclin D, E, and A) and tumor suppressor proteins (p27, p21, and p53) were assessed by real time RT-PCR.
esults:  The cytotoxic effect of the extract on normal human cells was significantly different from its effects on HeLa and HepG2 cells, 251.28 ±  4.3,
3.38 ±  1.87, and 28.66 ±  2.85 mg/ml, respectively. The selectivity index (SI) was 10.88 ±  0.82 for HeLa and 8.93 ±  0.81 for HepG2 cells. Increased
evels of TNF, but not IFN  were observed in the treated HeLa and HepG2 culture supernatants when compared with untreated cells. RC extract
nduced G0/G1 phase arrest in the cancer cells. The extract induced apoptosis, in a dose and time dependent manner, in treated HeLa and
epG2 cells while no observed apoptosis was found in untreated cells. Moreover, RC IC50 showed remarkable influence on the expression of the
poptosis-related genes in a positive and negative manner on both HeLa and HepG2 cells.
iscussion/conclusion:  RC extract could be considered as a novel anticancer agent providing new prospects for anticancer therapy using a natural
roduct.
 2013 Published by Elsevier GmbH.
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More effort is needed to control the increasing incidence
f human malignancies worldwide. In an effort to win the
ombat against cancer, research across the globe has focused on
dentifying, characterizing, and providing the scientific basis to
he efficacy of various plant-based drugs which could be used
o control various human malignancies [1]. One of the reasonsity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
or focusing on natural products as potential anticancer agents
s the growing resistance to chemotherapeutic drugs in cancer
atients[2]. Moreover, numerous studies have shown that
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arious natural products can interfere with different stages of
ancer development, and may effectively block malignancy [1].
Recently, red cabbage (Brassica  oleracea  L. var. capitata
. rubra  DC), which belongs to the family Brassicaceae, has
ttracted much attention because of its potential application
n physiological functioning [3]. Red cabbage is a rich source
f phenolic compounds, with the anthocyanins being the most
bundant class; they have been found to be responsible for the
ain biological properties of RC [4,5]. Some studies have shown
he ability of red cabbage extract to suppress oxidative stress
n vivo [6,7]. Others have focused on its anticancer [8–10], anti-
nflammatory [11], antibacterial [8], and anti-diabetic effects
12].
The current study explores possibly for the first time, the
otential anticancer activity of red cabbage extract by using a
ophisticated approach of molecular and cytotoxic methodolo-
ies. It also aimed to explore the possible mechanisms used by
he active components of this extract, if any, to inhibit selectively
he proliferation of human cancer cell lines. The current study
as designed to determine whether RC extract had the poten-
ial to induce apoptosis in cancer cells and arrest the cell cycle
sing two techniques, namely flow cytometry and RT qPCR
hich together detect and measure apoptosis and apoptosis-
nducing factors. Moreover, this study determined the level of
nticancer cytokines and measured the expression level of genes
ith anticancer activity, namely genes involved in apoptosis,
ell cycle regulation and tumor suppressor proteins, in human
ancer cell lines after being treated with red cabbage methanol
xtract.
aterials  and  methods/Methodology
reparation  of  the  extract
Fresh red cabbage (RC) was purchased from local market
rown in tropical area conditions (30 ◦C and 80+ humidity) in
he state of Selangor, Malaysia. The dark colored medium sized
eaves were collected in September. The cabbage leaves were
ut into small pieces and left to dry in dark area for seven days
t room temperature. Finally, leaves were ground to powder. The
round powder was extracted 1:10 wt/v with 2.4 mol/L HCl acid-
fied methanol (Merck, Darmstadt, Germany) in order to extract
ll components of phenolic compounds, free and conjugated
13]; the ground powder was then soaked in a dark area for three
ays at room temperature. The solvent was removed by filtration
nd fresh solvent was added to the plant material. The extraction
rocedure was repeated twice and the extract was evaporated to
ryness under vacuum at 40 ◦C. The pH of RC extract was neu-
ral ranging from 6.8 to 7.2. The powder was stored at −18 ◦C
n desiccant until further use. The stock extract was prepared by
edissolving in 0.1% dimethyl sulfoxide (DMSO), (BIO BASIC
NC., NY, USA) as this concentration was shown to be non toxicPlease cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
o cell culture [14]. The dissolved suspension was centrifuged at
34 ×  g  for 10 min and was filtrated by 0.22 m Millipore filters
Nalgene, UK).
w
s
f
6tive Medicine xxx (2013) xxx.e1–xxx.e15
ell  culture
Two lines of human cancer cells along with normal human
ells were used to evaluate the anticancer effects of RC extract.
he cancer cell lines were cervix adenocarcinoma (HeLa;
TCC CCL-2) and hepatocellular carcinoma cells (HepG2;
TCC HB-8065), while the normal human cells were periph-
ral blood mononuclear cells (PBMC). Human PBMC were
solated by density gradient centrifugation technique from hep-
rinized whole blood as described previously [15]. PBMC were
ropagated in humidified 5% CO2 atmosphere at 37 ◦C using
PMI-1640 culture medium w/l-glutamine (biowest, FL, USA)
upplemented with 10% fetal bovine serum (FBS) (Sigma,
ermany), 50 U/ml penicillin-streptomycin (biowest, Florida,
SA), and 2.5 g/ml amphotericin B (biowest, FL, USA). Try-
an blue solution 0.4% (Sigma, Germany) was used to count
he cells in order to adjust them to an appropriate concentration,
nd the viability of cells was checked to be within the required
ange of viability, which is 95–99%.
ytotoxicity  assay
TS  assay
In order to determine the cells viability, the MTS colori-
etric method (the Cell Titer 96® Aqueous One Solution Cell
roliferation Assay, Promega, USA) was used. Briefly, purified
ononuclear cells, 2 ×  105 cell/well, were cultured, in qua-
ruplicates, in 96-well U-bottom tissue culture plates (Orange
cientific, Europe) with 2-fold serial dilutions of RC extract in
PMI-1640 culture medium. The extract concentrations ranged
rom 317 to 9.9 mg/ml. The negative control wells, in qua-
ruplicates, contained PBMC in RPMI-1640 culture medium
hile the positive control wells, in quadruplicates, contained
BMC with Concavalin A (Con A), (10 g/ml), a T-cell spe-
ific mitogen (Sigma, Germany). The final volume in the wells
as 200 l/well. Cultures were incubated in humidified 5% CO2
tmosphere at 37 ◦C for 72 h.
The cytotoxic effect of RC extract on the human cancer
ell lines was performed according to the established method
16], where 1 × 105 cell/well viable HeLa and HepG2 cells were
rown in RPMI-1640 culture medium in 96-well flat-bottom
issue culture plates (Orange Scientific, Europe). The plates
ere incubated in humidified 5% CO2 for 24 h at 37 ◦C. When
ells reached >80% confluence, the medium was replaced with
00 l/well of 2-fold serial dilutions of RC extracts from 250
o 15.62 mg/ml prepared in RPMI-1640 maintenance medium
with 2% FBS). The negative control wells contained DMSO
0.1%) in RPMI-1640 maintenance medium. The final volume
n all of the wells was 200 l/well, in quadruplicates. All the
lates were incubated in humidified 5% CO2 for 24 h at 37 ◦C.
ater, the wells’ contents were removed and replaced with
00 l/well of RPMI-1640 maintenance medium. The platesity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
ere re-incubated for 48 h at the same conditions.Finally, MTS
olution was added to each well. The plates were incubated
or 4 h. The absorbance was measured at 490 nm (reference
90 nm) using a 96-well plate ELISA reader (Sunrise Basic
ARTICLE IN PRESS+ModelEUJIM-252; No. of Pages 15
tegra
T
t
c
c
w
a
A
I
a
i
I
C
i
H
1
i
s
i
n
n
2
t
w
b
n
k
t
U
r
m
6
p
f
w
t
F
i
5
r
R
t
g
d
w
fi
w
2
(
i
a
a
a
(
u
T
w
o
A
R
i
i
t
i
s
w
c
i
a
e
w
w
p
T
t
q
S
U
f
R
r
i
T
3
(
f
u
C
v
T
a
w
P
H
g
wR.R. Haﬁdh et al. / European Journal of In
ecan, Grödig, Austria). Each experiment was repeated for three
imes with four wells per dilution in each run.
The data of the extract cytotoxicity on PBMC and human
ancer cell lines were calculated using the following formula:
ytotoxicity% =
[
1 −
(
ODt
ODc
)]
×  100
here (ODt) indicates the optical density of the tested extract
nd (ODc) indicates the optical density of the negative control.
ccordingly, the concentrations of 50% inhibition (CC50 and
C50) were the concentrations that achieved 50% cytotoxicity
gainst PBMC and the cancer cells, respectively. The selectivity
ndex (SI) was the ratio of CC50 (cytotoxicity on PBMC) to the
C50 (cytotoxicity on human cancer cells) [17].
ytokines production  by  human  cancer  cell  lines
The level of anticancer cytokines, IFN  and TNF, was
nvestigated in treated and untreated HeLa and HepG2 cells.
eLa and HepG2 cells at 1 ×  105 cell/well were grown in RPMI-
640 culture medium in 96-well flat-bottom tissue culture plates
n a humidified 5% CO2 atmosphere for 24 h at 37 ◦C. Later,
erial 2-fold dilutions of RC extract, 20 to 0.62 mg/ml, prepared
n RPMI-1640 maintenance medium were added to the cells. The
egative control wells contained cells with RPMI-1640 mainte-
ance medium only. The final volume of all of the wells was
00 l/well, in triplicates. The plates were incubated for 48 h at
he same conditions. Afterwards, the supernatants from all the
ells were removed and centrifuged at 1000 ×  g  for 10 min to
e ready for the ELISA.
The cytokine concentrations in the culture medium super-
atant of cancer cells were determined by using sandwich ELISA
its. The manufacturers’ instructions for each kit were followed
o calculate IFN  concentrations by human ELISA kit (abcam,
SA) and TNF  concentrations by human enzyme immunomet-
ic assay (EIA) kit (Cayman, USA). Later, the absorbance was
easured at 412 nm (reference 690 nm) and 450 nm (reference
20 nm) using a 96-well plate ELISA reader for TNF  and IFN
lates, respectively. For each sample, the assay was repeated
or three times. The concentrations of the anticacncer cytokines
ere determined by extrapolating their OD values with that of
he generated standard curves.
low  cytometry  analysis
The cells (HeLa and HepG2) were seeded (1 ×  105 cell/well)
n 6-wells tissue culture plates and were incubated in humidified
% CO2 atmosphere for 24 h at 37 ◦C. The medium was then
eplaced with RPMI-1640 maintenance medium with or without
C extract and was incubated for further 24 h at the same condi-
ions. The cell treatment was divided into two groups. In the first
roup (dose-dependent group), the effect of three 2-fold serial
ilutions of RC extract (concentration > IC50 > concentration)
as investigated regarding the level of apoptosis, if any, after aPlease cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
xed time (24 h). The concentrations of RC extract with HeLa
ere 46.76, 23.38, and 11.69 mg/ml while they were 57.32,
8.66, and 14.33 mg/ml for HepG2 cells. In the second group
time-dependent group), the IC50 of RC extract was used to
B
n
t
utive Medicine xxx (2013) xxx.e1–xxx.e15 xxx.e3
nvestigate the level of cells’ apoptosis as well as cell cycle
rrest after different time intervals of incubation with the extract
s indicated in the appropriate figure legend. For cell cycle
nalysis, the cells were fixed in 70% ethanol, stained with PI
MP Biomedicals, LLC, IIIKrick, France) and were analyzed
sing CyAn ADP apparatus (BECKMAN COULTER, USA).
he data were analyzed by software Summit (V4.3). The assay
as measured in duplicate for each sample in the specific time
f treatment.
nalysis  of  apoptosis
NA  extraction
The cells (HeLa and HepG2) were seeded, 1 × 105 cell/well,
n 6-wells tissue culture plates and were incubated in a humid-
fied 5% CO2 atmosphere for 24 h at 37 ◦C. The medium was
hen replaced with RPMI-1640 maintenance medium contain-
ng RC extract or alone in duplicates and was incubated at the
ame conditions. The IC50 of RC extract for each type of cells
as used. The IC50 of RC extract was 23.38 mg/ml for HeLa
ells and 28.66 mg/ml for HepG2 cells. It was observed that
ncubation for 12, 16 and 20 h with RC extract was optimal for
poptosis and cell cycle arrest studying when using flow cytom-
try. At the end of time interval for each cell type, all of the cells
ere harvested and transferred to 15 ml tubes. The supernatants
ere discarded after being centrifuged at 134 ×  g  for 5 min. The
ellets were resuspended in PBS and were washed four times.
otal RNA was isolated according to the manufacturer’s pro-
ocol using GF-1 kit (Vivantis Technologies, Malaysia). RNA
uality and quantity were determined by Life Science UV/vis
pectrophotometer, DU Series 700 (BECKMAN COULTER,
SA).The isolated RNA was stored at −80 ◦C and was ready
or use.
eal  time  quantitative  RT-PCR
One microgram of the isolated RNA from each sample was
everse transcribed according to the manufacturer’s protocol
ScriptTM cDNA Synthesis Kit (BIO-RAD, Hercules, Canada).
he complete reaction mix was incubated for (5 min 25 ◦C,
0 min 42 ◦C, then 5 min 85 ◦C) using Thermo Bath, ALB64
FINEPCR, Seoul, Korea). Finally, cDNA was stored at −80 ◦C
or the qRT-PCR reaction.
Real-time quantitative PCR reaction was conducted
sing SsoFastTM EvaGreen® Supermix (BIO-RAD, Hercules,
anada). According to the manufacturer’s protocol, a final
olume of 20 l cDNA was run for 40 cycles by CFX96TM Real-
ime System (BIO-RAD, Hercules, Canada) using the forward
nd reverse primers mentioned in Table 1. Cycling conditions
ere 3 min 95 ◦C, 10 s 95 ◦C, 30 s 55–61 ◦C, and 20 s 72 ◦C.
CR reaction for cDNA templates from untreated HeLa and
epG2 cells were used as negative controls. For each target
ene, the PCR reaction was run in triplicates. PCR reaction mix
ithout cDNA template was used to detect any contamination.ity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
eta-actin was used as a housekeeping gene (reference gene) to
ormalize the mRNA expression of target genes. At the end of
he amplification, Eva Green fluorescence was measured contin-
ously for the conduction of the melting curve analysis by slow
ARTICLE IN PRESS+ModelEUJIM-252; No. of Pages 15
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Table 1
Primers used in Real-Time quantitative PCR analysis (Vivantis Technologies, Malaysia).
Forward primer Reverse primer
Bax CAC CAG CTC TGA GCA GAT GCG AGG CGG TGA GCA CTC
BCL-2 TAC CTG AAC CGG CAC CTG GCC GTA CAG TTC CAC AAA GG
Caspase 7 GTC TCA CCT ATC CTG CCC TCA TTC TTC TTC TGC CTC ACT GTC
Caspase 8 GAA AAG CAA ACC TCG GGG ATA C CCA AGT GTG TTC CAT TCC TGT C
Caspase 9 CCA GAG ATT CGC AAA CCA GAG G GAG CAC CGA CAT CAC CAA ATC C
Cyclin D AGA CCT GCG CGC CCT CGG TG GTA GTA GGA CAG GAA GTT GTT C
Cyclin E CTC CAG GAA GAG GAA GGC AA TCG ATT TTG GCC ATT TCT TCA
Cyclin A GTC ACC ACA TAC TAT GGA CAT G AAG TTT TCC TCT CAG CAC TGA C
p21 GTG ATT GCG ATG CGC TCA TG TCT CTT GCA GAA GAC CAA TC
p27 GTC TAA CGG GAG CCC TAG CC CTA ACC CCG TCT GGC TGT CC
p53 TGT GGA GTA TTT GGA TGA CA GAA CAT GAG TTT TTT ATG GC
-actin (reference gene) TCA CCC TGA AGT ACC CCA TC CCA TCT CTT GCT GCA AGT CC
Note: All primers are listed 5′–3′.
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of RC extract decreased with lower concentrations of the
extract. The significant differences of RC cytotoxicity between
normal and cancer cells were supported by the results of theeating at 0.5 ◦Cs-1 increments from 70 to 95 ◦C. Accordingly,
 melting curve was generated at the end of the PCR amplifi-
ation for monitoring the specificity of PCR reaction. Melting
urve analysis of the negative first derivative was pursued. The
fficiency of PCR primers was done as described by [18]. The
ata were analaysed using software BIO-RAD CFX Manager
V 1.1.308).
It has been well known that the ratio of Bax to Bcl-2 deter-
ines, in part, the susceptibility of cells to death signals [19].
herefore, the Bax to Bcl-2 ratio was calculated using the fol-
owing equation:
Bax
Bcl-2 ratio
= (mean PCR efficiency for Bax and Bcl-2) (CtBcl2 − CtBax)
ata  analysis
Data are presented as mean ±  2SE. The data analysis was
onducted by using SPSS software version (12.0.0.2). The
ffect of RC extract on the inhibition of cell growth was
valuated by using 95% confidence intervals. IC50 and CC50
alues were calculated using linear regression index equations.
he statistically significant effects of the extract on the abil-
ty of HeLa and HepG2 cells to synthesize selected cytokines
ere compared with the control groups using Student’s t-test.
or flow cytomteric analysis, R2 fraction represented sub-G
poptotic cells; moreover, the percentage of cells at different
ell cycle phases was calculated from the total cells minus
poptotic cells. For quantitative real time PCR, the up- or
own-regulation of mRNA expression of selected genes was
easured as expression fold changes in term of mean ±  2SD.Please cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
he significance of up- or down-regulation of the normalized
RNA expression of selected genes was determined by com-
aring the mean ±  2SD of any up- or down-regulation with
he mean ±  2SD of control (untreated cells), which is of mean
qual to 1 ±  2SD. P  values less than 0.05 were considered
ignificant.
F
oesults
ytotoxicity  of  RC  extract  on  two  human  cancer  cell  lines
The results of thisexperiment revealed that the cyto-
oxic effects of RC extract on normal human cells
PBMC) were significantly different (P  < 0.05) from that on
uman cancer cells. The cytotoxic effect of RC extract
n PBMC (CC50 = 251.28 ±  4.3 mg/ml) was lower than on
eLa cells (IC50 = 23.38 ±  1.87 mg/ml) and HepG2 cells
IC50 = 28.66 ±  2.85 mg/ml). The results revealed that RC
xtract required high concentrations to be cytotoxic for the nor-
al human cells (Fig. 1), while even low extract concentrations
ere enough to give the same effect on the human cancer cells
Fig. 2). These results reflected the good selectivity and safety
f RC extract as a candidate anticancer agent.
The cytotoxicity of RC extract on PBMC, HeLa and HepG2
ells was dose dependent. In other words, the cytotoxicityity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
ig. 1. The percentage of PBMC death after treatment with 2-fold serial dilutions
f RC extract in term of mean ± 2SE (confidence interval CI 95%).
Please cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
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Fig. 2. The percentage of (A) HeLa and (B) HepG2 cells death after treatment
with 2-fold serial dilutions of RC extract in term of mean ± 2SE (confidence
interval CI 95%).
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Fig. 3. Figures demonstrate the level of the produced cytokines, in comparison with
with red cabbage extract (RC): (a) IFN and (b) TNF.
Fig. 4. Figures demonstrate the level of the produced cytokines, in comparison with 
with red cabbage extract (RC): (a) IFN and (b) TNF.tive Medicine xxx (2013) xxx.e1–xxx.e15 xxx.e5
electivity index (SI) which represents the ratio of the highest
oncentration that causes 50% death to normal cells (CC50) to
he lowest concentration that causes 50% death to cancer cells
IC50). The SI values of RC extract on HeLa and HepG2 cells
ere 10.88 ± 0.82 and 8.93 ±  0.81, respectively. There was no
ignificant difference (P  > 0.05) in the cytotoxic effect of RC
xtract on both cell lines.
peciﬁc  immune  response  by  human  cancer  cells
The human cancer cell lines were treated with extract con-
entrations less than the IC50. These concentrations allowed
he production of anticancer cytokines, if any, in the culture
upernatants of HeLa and HepG2 cells (Figs. 3 and 4). The
nticancer effect of RC extract on HeLa and HepG2 cells was
artly investigated by detecting and measuring IFN  and TNF
evels in the cell culture supernatants. No significant differ-
nces (P  > 0.05) in IFN  levels were found between the treated
nd untreated HeLa and HepG2 cells with RC extract while
he levels of TNF  showed considerable increase (P  < 0.05) inity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
eLa and HepG2 culture supernatants treated with RC extract
n comparison with the control group (untreated cells). This
ncrease was in a dose-dependent manner with RC extract
oncentrations.
 negative control (neg-ctl), in culture supernatant of HeLa cell after treatment
negative control (neg-ctl), in culture supernatant of HepG2 cell after treatment
Please cite this article in press as: Hafidh RR, et al. Novel anticancer activity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.06.004
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Fig. 5. DNA content frequency histograms representing HeLa cells after 24 h from (a) untreated cultures (b) cultures treated with RC extract concentration < IC50
(c) cultures treated with RC extract IC50 (d) cultures treated with RC extract concentration > IC50. The treatment affected the cell cycle distribution and induced
apoptosis. The cells were stained with PI. Fluorescence of the PI-stained cells was measured using CyAn ADP appartus and Summit (V4.3) software. The software
program provides the estimate of percentage of cells with fractional DNA content (apoptotic cells: R2) and cells in G0/G1 (R3), S (R4), and G2/M (R5) phases of
the cycle. Total cell number (R1).
Please cite this article in press as: Hafidh RR, et al. Novel anticancer activity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.06.004
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Fig. 6. DNA content frequency histograms representing HepG2 cells after 24 h from (a) untreated cultures (b) cultures treated with RC extract concentration < IC50
(c) cultures treated with RC extract IC50 (d) cultures treated with RC extract concentration > IC50. The treatment affected the cell cycle distribution and induced
apoptosis. The cells were stained with PI. Fluorescence of the PI-stained cells was measured using CyAn ADP appartus and Summit (V4.3) software. The software
program provides the estimate of percentage of cells with fractional DNA content (apoptotic cells: R2) and cells in G0/G1 (R3), S (R4), and G2/M (R5) phases of
the cycle. Total cell number (R1).
ARTICLE IN PRESS+ModelEUJIM-252; No. of Pages 15
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Fig. 7. The graph of flow cytometric analysis shows the percentage of apoptotic
cells after treatment with RC extract for 24 h and in comparison with untreated
cells (Negative control). The extract’s concentrations represent 2-fold serial dilu-
tions (concentration > IC50 > concentration). (A) Apoptotic % of HeLa cells. (B)
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Fig. 8. The graph of flow cytometric analysis shows the percentage of apoptotic
cells after treatment with IC50 of RC extract in comparison with untreated cells.
The percentage of apoptotic cells increased with the time of treatment. (A)
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cpoptotic % HepG2 cells. The increase in the percentage of the apoptotic cells
as dose dependent.
C  extract  induced  apoptosis  and  cell  cycle  arrest  in  human
ancer cells
Apoptosis in the cells treated with RC extract was measured
sing flow cytometry. The cytotoxicity of RC extract was shown
o be selective on cancer rather than normal cells. It is noteworthy
o mention that physiological properties (pH, temperature and
onic strength) of the RC extract diluted in RPMI medium were
ithin normal range; this minimizes the chance of extract-driven
ecrosis and suggests? That apoptosis was the type of cell death
etected by flow cytometry. However, apoptosis was confirmed
y integrating the results of both flow cytometry and RT-qPCR.
he flow cytometric analysis showed remarkable potential of RC
xtract to induce apoptosis in the treated cells in comparison to
ntreated cells (Figs. 5 and 6). By testing the apoptosis for a
xed time interval, 24 h, and different doses of RC extract, the
ercentage of the apoptotic cells was directly correlated with the
oncentration of RC extract. The extract induced apoptosis, in a
ose dependent manner, in treated HeLa and HepG2 cells while
o observed apoptosis was found in untreated cells (P  < 0.05). By
sing the IC50 of RC extract for 24 h treatment, 48.2 and 53.7%
f HeLa and HepG2 cells, respectively, underwent apoptosis
Fig. 7).Please cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
The flow cytometric analysis of HeLa and HepG2 cells treated
ith the IC50 of RC extract revealed an increase in the per-
entage of the apoptotic cells in a time dependent manner. The opoptotic % of HeLa cells. (B) Apoptotic % of HepG2 cells. The increase in
he percentage of the apoptotic cells was time dependent.
poptotic cells increased significantly (P  < 0.05) in the treated
ell cultures when compared with untreated cell cultures, and
his increase was directly proportional with duration of incu-
ation with RC extract (Fig. 8). For the phases of cell cycle,
xcept for 16 h time interval, there were no significant differ-
nces (P  > 0.05) among the percentage of cells at different cell
ycle phases, G0/G1, S, and G2/M, of HeLa and HepG2 cells
reated with RC IC50. The replicates’ mean percentage of cells
t G0/G1 phase at all of the time intervals (8, 12, 16, 20, 24, 28,
nd 72 h) in RC extract-treated Hela and HepG2 cells, except
or the 8 h interval in Hela cells, was significantly higher than
he replicates’ mean percentage of cells at G0/G1 phase for the
orresponding time intervals in the untreated cells (P  < 0.05).
nd the optimal time for maximal G0/G1 cell cycle arrest was
ound to be at 16 h (Figs. 9 and 10). In other words, RC extract
ignificantly induced G0/G1 phase arrest in treated HeLa and
epG2 cells.
he  apoptosis-  and  cell  cycle-related  genes  in  human
ancer cells  treated  with  RC  extractity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
Cultivation of cells with RC extracts for 12, 16, and 24 h was
ptimal for measuring expression level of the apoptosis- and cell
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Fig. 9. The percentage of cells at G0/G1, S, G2/M phases of cell cycle as an
indicator for cell cycle arrest in (A) HeLa cells treated by the IC50 of RC extract,
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Fig. 10. The percentage of cells at G0/G1, S, and G2/M phases of cell cycle as
an indicator for cell cycle arrest in (A) HepG2 cells treated by the IC50 of RC
e
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mnd in (B) untreated HeLa cells at different time intervals at 8, 12, 16, 20, 24,
8, and 72 h.
ycle-related genes using real-time quantitative PCR. The other
reatments of 8, 24, 48, and 72 h were ignored because they either
ave very low or very high percentage of apoptotic cells. Study-
ng the apoptosis- and cell cycle-related genes cannot be covered
ell during very early phase of extract’s treatment when some of
he apoptosis genes are still not expressed; alike, during very late
hase of apoptosis, most cells already died which renders mea-
uring the expression of selected genes erroneous. The melting
urve analysis showed single peak of melting temperature (Tm)
6–87 ◦C, while no significant premature peaks were found indi-
ating that primer dimers were minimal and providing further
vidence on the specific detection of the target mRNA genes
data not shown). The PCR efficiency of the primers used was
reater than 90% and the correlation coefficients were greater
han 0.99.
RC IC50 showed remarkable influence on the expression of
he apoptosis-related genes in a positive and negative manner
n both HeLa and HepG2 cells (Fig. 11). The expression of
ax gene in HeLa and HepG2 cells was upregulated (P  < 0.05)
fter 12, 16, and 20 h treatments with RC IC50 (P  > 0.05) while
cl-2 gene expression was downregulated (P  < 0.05) in HeLa
ells after 12, 16, and 20 h, and in HepG2 cells after 12 h of
reatment with RC IC50. Caspase 7 gene expression was foundPlease cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
o be upregulated after 16 h of treatment of HeLa cells with RC
C50 (P < 0.05) while Caspase 7 gene expression in HepG2 cells
as upregulated after 12 and 16 h of treatment with RC IC50
o
H
txtract, and in (B) untreated HepG2 cells at different time intervals at 8, 12, 16,
0, 24, 48, and 72 h.
P  < 0.05). Moreover, RC IC50 upregulated the expression of
aspase 8 gene in both HeLa and HepG2 cells after 12 and 16 h
P < 0.05). The current study also revealed that treating HeLa and
epG2 cells with RC IC50 upregulated Caspase 9 expression
ainly after 12 and 16 h (P  < 0.05).
The ratio of Bax to Bcl-2 proteins influences the apoptotic
ate of cells; therefore, Bax/Bcl-2 ratio was calculated in treated
nd untreated HeLa and HepG2 cells. The Bax/Bcl-2 ratio in
eLa cells treated with RC IC50 for 12 h (7.26 ±  1.1) and 16 h
14.3 ±  3.5), but not at 20 h (3.71 ±  0.75), was higher (P  < 0.05)
han for untreated cells (0.22 ±  0.01). The Bax/Bcl-2 ratio in
he treated HepG2 cells with RC IC50 after 12 h (11.15 ±  2.5),
6 h (12.49 ±  3.45), and 20 h (3.05 ±  0.67) was higher (P  < 0.05)
han in untreated cells (0.37 ±  0.04).
Flow cytometric analysis showed cell cycle arrest at G0/G1
hase of cancer cells treated with RC extract; therefore, the reg-
latory proteins of G0/G1 phase in the mammalian cell cycle,
yclin D, E, and A were studied. These cyclins are responsible
or the activation of cyclin-dependent kinases (cdk) in G1 and S
hases of the cell cycle in HeLa and HepG2 cells. Moreover, the
RNA expression of the proteins responsible for the inhibitionity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
f cyclin-cdk active complexes of G1 and S phases of HeLa and
epG2 cells treated with RC extract was studied as well, namely
umor suppressor proteins p27, p21, and p53 (Fig. 12).
Please cite this article in press as: Hafidh RR, et al. Novel anticancer activity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.06.004
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Fig. 11. Real-time quantitative PCR analysis illustrates the gene expression in (A) HeLa cells and (B) HepG2 cells after 12, 16, and 20 h of treatment with the IC50
of RC extract. The gene expression was normalized with the reference gene (-actin). The relative quantification of the target genes, Bax, Bcl-2, Caspase 7 (Casp 7),
Caspase 8 (Casp 8), and Caspase 9 (Casp 9), by the delta–delta–Ct method was done using the software BIO-RAD CFX Manager (V 1.1.308).
Fig. 12. Real-time quantitative PCR analysis illustrates the gene expression in (A) HeLa cells and (B) HepG2 cells after 12, 16, and 20 h of treatment with the IC50
of RC extract. The gene expression was normalized with the reference gene (-actin). The relative quantification of the target genes, Cyclin D (CYCD), Cyclin E
(CYCE), Cyclin A (CYCA), p27, p21, and p53, by the delta–delta–Ct method was done using the software BIO-RAD CFX Manager (V 1.1.308).
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The results of real time PCR granted valuable details on
he underlying mechanisms of the potential of RC extract to
nduce cell cycle arrest. For HeLa cells, it was found that both
yclin D and E were not significantly affected by exposure to
he RC extract after 12, 16, and 20 h (P  > 0.05) except for cyclin
 which was slightly downregulated after 16 h (P  < 0.05). Sur-
risingly, cyclin A was upregulated significantly after 12 and
6 h (P  < 0.05) but not after 20 h (P  > 0.05); however, cyclin A
pregulation was not prominent, up to 8–16 folds of expres-
ion only. On the other hand, p27 was significantly upregulated
fter 12 h, more than 8 folds, (P  < 0.05) but not after 16 or 20 h
P > 0.05). This indicated that RC extract induced synthesis of
27 at early phases of exposure and its effect lasts for a short
eriod of time. On the contrary, the upregulation of p21 and
53 was not significant (P  > 0.05) after 12 and 20 h whereas
21 and p53 upregulation was significant after 16 h, up to 8 and
2 folds, respectively (P  < 0.05). This finding provides evidence
hat the activity of p53 and p21 starts later than p27 for inhibiting
yclin-cdk complexes at G0/G1 phase of the cell cycle.
For the effect of RC extract on HepG2 cells, it was found
hat cyclin D and A expression was not affected by RC extract
fter 12, 16, and 20 h (P  > 0.05) while cyclin E was found sig-
ificantly, but slightly, upregulated after 12 and 20 h (P  < 0.05)
ut not after 16 h (P  > 0.05). These findings show the presence
f more than one component in RC extract affecting, in differ-
nt ways, the cell cycle of HepG2 cells. It appears that there
s a component stimulates cyclin E rather than other cyclins,
ut this stimulation was counteracted by the stimulation of cdk
nhibitors, p27, p21, and p53 especially after 16 h. The level of
RNA expression of p27 and p21 was largely upregulated after
2 and 16 h and of p53 after 16 h only (P  < 0.05).
iscussion/conclusion
The anticancer activity of RC extract was investigated on
wo of the most important types of cancer in Asian countries.
epending on the recent studies, hepatocellular carcinoma is
onsidered to be one of the most common cancers worldwide
ith an extremely poor prognosis [20,21]. On the other hand,
ervical cancer continues to be the commonest cause of death
mong women in developing countries and is the second most
requent cancer among females worldwide [22,23]. This study
ocused on these two human cancers in an attempt to explore
hether their anticancer therapy could be augmented with an
nder-investigated natural product, namely the red cabbage.
The findings in the current study revealed effective anticancer
ctivities on HeLa and HepG2 cells by RC extract. Since the SI
iological efficacy, or SI, ≥10 indicates specific cytotoxicity
24], the selectivity of RC extract on HeLa cells was signifi-
antly evident (SI = 10.88) while the selectivity of RC extract
n HepG2 cells (SI = 8.93) was less remarkable. The noticeable
nticancer activity of RC methanol extract on HeLa and HepG2
ells in this study is in agreement with the findings of a KoreanPlease cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
tudy [8] which found that RC methanol fraction had an anti-
ancer activity against HeLa and HepG2 cells. In addition, the
hemopreventive effects of cruciferous vegetables, particularly
C, against different types of cancer have been demonstrated
i
a
i
otive Medicine xxx (2013) xxx.e1–xxx.e15 xxx.e11
y previous studies [25,26]. The chemopreventive effect of RC
ay be due to the high flavonoid contents, precisely, antho-
yanins [27]. The critical anticancer activity of RC extract in
his study is most probably due to the anticancer activity of
avonoids. It has been found that flavonoids act as antioxidants,
ssentially disabling the carcinogenic potential of specific com-
ounds by having cytoprotective effects against ONOO- and
OCl mediated cytotoxicity [28,29]. Additionally, the ability of
avonoids to scavenge free-radicals and block lipid peroxida-
ion raises the possibility that they may act as protective factors
gainst carcinogenesis [30,31].
As mentioned earlier, anthocyanins are the major flavonoid
omponents in RC. Thus, the results of the current study may be
ttributed in part to the anticancer activity of anthocyanins, as
 subclass of the flavonoids. The anthocyanins anticancer activ-
ty was recorded by many studies [32,33]. It has been shown
hat anthocyanins demonstrate varied anticancer activities such
s strong free radical scavenging and antioxidant activities [34],
aving the ability to inhibit the hormonal actions and metabolic
athways associated with cancer development, and inducing
hase I or II detoxification enzymes [9,35,36]. Interestingly,
ifferent mechanisms, which may be used by anthocyanins as a
ubclass of flavonoids in RC, may be responsible for the promis-
ng anticancer activity of RC and may effectively reduce the
hances for the development of anticancer resistance against
his extract.
The current study also attempted to investigate the mech-
nism(s) of RC anticancer activities. Since the increased
xpression of anticancer cytokines, namely IFN  and TNF,
xplains the anticancer activity of any extract [37], we measured
he expression levels of IFN  and TNF  in the culture super-
atants of HeLa and HepG2 cells treated with RC extract. The
urrent study revealed an increased level of TNF, but not IFN,
n the culture supernatants of HeLa and HepG2 cells treated
ith RC extract, in a dose dependent manner, when comapred
o untreated cells. The growth inhibition manifested in HeLa and
epG2 cells trated with RC extract may be, partly, due to the
ntitumor effect of TNF. These findings could be supported by
he fact that TNF  is a pleiotropic cytokine originally identified
ue to its antitumor activity [38]. Moreover, TNF  was one of
he first cytokines used in treating cancer. It can induce cancer
ell death via TNF-driven programmed cell death or apoptosis
39]. It was shown that anthocyanins can induce apoptosis by
he extrinsic pathway [36]; alike, TNF  can induce apoptosis
y the extrinsic pathway. So, the effect of anthocyanins in RC
xtract may induce the production of TNF  from human cancer
ells which in turn induce cell death in these cancer cells.
Flow cytometry analysis was used to investigate the presence
r absence of apoptotic cells in the treated HeLa and HepG2
ells. The results revealed that the RC extract induced apopto-
is and cell cycle arrest in G0/G1 phase in the treated cells in a
ose and time dependent manner. The cell cycle arrest and the
nduction of apoptosis in cancer cells have become the majority and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
ndicators of anticancer effects [40]. The antitumor effects are
ttributed to altered biochemical mechanisms, including mainly
nhibitions of proliferation, induction of cell cycle arrest at vari-
us cell cycle checkpoints, and enhanced apoptosis [41]. More to
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he point, the current study is in agreement with previous studies
hich found that flavonoids, phenolic acids, and other antioxi-
ants have the ability to inhibit the cancer cell cycle progression,
ell proliferation and tumor growth by inducing cell-cycle arrest
nd apoptosis [42,43].
Subsequently, real-time quantitative PCR was used to con-
rm the RC-driven apopotisis detected by flow cytometry and to
etect the mechanism(s) used by RC extract to induce apoptosis.
herefore, the expression of several apoptosis-related genes was
nvestigated quantitively. Apoptosis is a broad network of sig-
als that act through two major apoptotic pathways: the extrinsic
eath receptor pathway (via caspase 8), which triggers the acti-
ation of a caspase cascade, and the intrinsic mitochondrial
athway (via caspase 9), which shifts the balance in the Bcl-
 family toward the pro-apoptotic members and, consequently,
oward caspase-mediated apoptosis [44]. Both caspase 8 and 9
re considered initiator caspases which in turn can activate the
ffector caspases, caspase 3 and caspase 7, leading to the dra-
atic morphologic changes of apoptosis [45]. In this study, RC
xtract upregulated the gene expression of caspase 8 in treated
eLa and HepG2 cells. This upregulation was manifested sig-
ificantly after 12 h of treatment suggesting that this time was
he beginning of the apoptosis induction via caspase 8 pathway.
t has been shown that the activation of caspase 8 requires the
nvolvement of apoptotic ligands such as TNF  and Fas ligand
44]. As mentioned earlier, RC extract stimulated TNF  produc-
ion in the culture supernatants of the treated HeLa and HepG2
ells. Thus, we propose that TNF  which was produced by the
reated cells might have an autocrine effect on the same produc-
ng cells. It might activate the extrinsic apoptosis pathway via
aspase 8 by binding to its receptors on the surface of cancer
ells.
The current results revealed that RC extract upregulated the
xpression of Bax gene after 12 h of treatment and this upre-
ulation continued till 20 h. It has been stated that cytochrome
 release from mitochondria could be controlled by Bax and
he translocation of Bax can alter the outer mitochondrial mem-
rane permeability, leading to cytochrome c  release from the
itochondria to the cytosol then activation of the intrinsic apo-
tosis pathway [46,47]. Accordingly, RC extract promoted the
ntrinsic apoptosis pathway partly by its ability to upregulate
ax gene. Moreover, RC extract downregulated the expression
f Bcl-2 gene after 12 h of treatment of both HeLa and HepG2
ells. These results revealed the predominance of Bax gene over
cl-2 gene in all of the treated cells. It was proven that the ratio
f Bax to Bcl-2 determines, in part, the susceptibility of cells to
eath signals [19]. It was shown that changes in the Bax/Bcl-2
atio could be caused by downregulation of Bcl-2 and upregula-
ion of Bax [48]. For that reason, Bcl-2 proteins have emerged
s an attractive target for the development of novel anticancer
rugs [49] and this could be one of the targets hit by RC active
ompounds to induce apoptosis.
The upregulation of caspase 9 in the treated HeLa and HepG2Please cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
ells was evident after 12 h of treatment with RC extract. It is
ell known that caspase 9 can be activated by caspase 8 or can be
ctivated independently on binding of cytochrome c  release from
he mitochondria [46]. Therefore, we assume that the intrinsic
c
o
s
wtive Medicine xxx (2013) xxx.e1–xxx.e15
poptosis pathway induced by RC extract in the treated cancer
ells might be provoked via direct upregulation of caspase 9
ene, via the activation of caspase 8 by the extrinsic pathway, or
ia the upregulation of Bax gene.
The upregulation of caspase 7 gene in the treated HeLa cells
ith RC extract started at 16 h while it started at 12 h in treated
epG2 cells. Moreover, caspase 7-dependent pathway without
aspase-3 activation now is considered as caspase-independent
poptosis pathway. And caspase 7 can activate caspase 12 which
esults in the induction of apoptosis during endoplasmic reticu-
um stress [50]. Therefore, the results of this study disclosed
 fact that RC extract might induce apoptosis by different
athways. The possible reason behind these findings might be
ealing with a crude extract composed of different components
hat might trigger different pathways of apoptosis. Accordingly,
sing RC extract shows advantage of triggering two or three
athways of apoptosis simultaneously leading to vigorous induc-
ion of apoptosis. The induction of multi-pathway apoptosis
sually leads to effective anticancer activity able to overcome
ny resistance that might be issued? By cancer cells against
poptotic signals. In addition, the current results highlight the
bility to isolate more than one effective anticancer component
rom RC extract.
The regulatory proteins of the cell cycle studied in the current
tudy were chosen carefully to give a clear image on the under-
ying mechanisms and pathways for the G0/G1 arrest observed
n HeLa and HpeG2 cells treated by RC extract. The stud-
ed markers were cdk-activating proteins, namely cyclins and
dk-inhibitors, or CKI, namely tumor suppressor proteins such
s p27, p21, and p53. Cdk activation requires cyclin binding
nd phosphorylation of conserved threonine residue by cdk-
ctivating kinase. On the other hand, the activated cdk–cyclin
omplexes can be changed to an inactive state by phosphory-
ation of a conserved threonine–tyrosine pair or binding to cdk
nhibitory subunits, or tumor suppressor proteins such as p53,
21, p27, p15, and p16 [51]. The mRNA expression of cyclins
, E, and A was assessed by real time PCR while other cyclins
ere not covered. Progression from G1 to S phase in mammalian
ells is regulated by the accumulation of cyclins D, E and A,
hich bind to and activate different cdk catalytic subunits. The
ctivation of cdk4–cyclin D and/or cdk6–cyclin D complexes is
ecessary for the transition from early to mid G1 phase. Tran-
ition through mid G1 to S phase is regulated by activation of
he cdk2–cyclin E complex. And progression through late G1
o S phase also requires the presence of cdk2–cyclin A complex
52]. On the other hand, it was stated that cdk regulation involves
 diverse family of proteins, termed the CKIs (cdk inhibitors),
hat bind and inactivate cdk–cyclin complexes. Of these proteins
nvolved in G1 to S phases progression are p21, p53, and p27
53].
The effect of RC extract on both HeLa and HepG2 cells was
omparable but with minor differences. RC extract did not affect
he expression of cyclin D in both HeLa and HepG2 cells indi-ity and anticancer mechanisms of Brassica  oleracea  L. var. capitata
06.004
ating that cyclin D level is not the governing factor for the
bserved G0/G1 cell cycle arrest in flow cytometry. However,
urprisingly, cyclin E in HepG2 cells and cyclin A in HeLa cells
ere both upregulated at some times in response to RC extract.
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ctually this is a tumor progressing feature; however, the effect
f upregulated cyclins A and E was counteracted strongly by
xtensive and synchronous upregulation of three cdk-inhibitors
hich are p27, p21, and p53 especially after 16 h of exposure to
C extract. Hence, any upregulation of the cyclins of G1 phase
s counteracted and reversed by the activity of cdk inhibitor pro-
eins. The current feature indicates the presence of more than
ne component of contradicting effects in RC extract but the
ell cycle inhibitory effect is more prominent via the induction
f p21, p53, and p27 proteins. Accordingly, it is highly suspect
hat RC extract harbors two classes of affecter agents, one cell
rowth stimulating and other agents with cell cycle inhibitory
ctivities. Moreover, the differences found in the cyclins’ activ-
ty in response to RC extract between HeLa and HepG2 cells
rovide evidence for the cell type- specific interaction of RC
xtract. However, the overall or net result of the interplaying
actors in RC extract on both HeLa and HepG2 cells was clearly
oward arresting the cell cycle at G1 phase via inducing tumor
uppressor proteins.
Overall, the cell cycle inhibitory effects of RC extract
howed a weak or absent influence on the expression level of
dk-activating cyclins. Instead, RC extract showed remarkable
nduction and upsurge of cdk-inhibitor proteins. Therefore, it is
oncluded that these cdk-inhibitor proteins are the main mech-
nism pursued by RC extract to exert G1 cell cycle arrest and
ltimately final fate of cells, apoptosis. It is noteworthy to men-
ion that the inhibitory effect on cell progression by p21 is largely
xerted during G1 phase of the cell cycle, with preferential bind-
ng to cdk4- and cdk2-containing complexes [54]. In addition,
he induction and regulation of expression of p21 is mainly
ependent on the active form of p53, a transcriptional regula-
or that mediates cell cycle arrest following DNA damage [55].
herefore, both p53 and p21 were expressed simultaneously
cting together on slowing or arresting G1 phase. G1 phase, the
rst part of the cell cycle is a restriction point, since all other
ell cycle compartments cannot be modified by interference
ith diverse proteins or enzymes. Therefore, stoppage of cells
hrough transition from G1 to S is most commonly found among
any cell cycle modifying chemicals. Another important cdk-
nhibitor, p27, is mainly regulated by proteasomal degradation
nd its downregulation is often correlated with poor progno-
is in several types of human cancers. The p27 protein is an
nconventional tumor suppressor because mutation of its gene
s extremely rare in tumors [56]; therefore, its upregulation by
ertain drugs or plants’ extracts appear as fascinating goal for
he anti-tumor therapy. P27 interacts with most actively engaged
dks of G1 phase, namely cdk 2, 4, and 6; moreover, it interacts
ith cyclins D, E, and A. Therefore, in the case of RC extract, the
hree cdk proteins, p53, p21, and p27, acted together powerfully
n slowing cell cycle at G1 phase and inducing apoptosis.
The current study revealed an interesting finding; RC extract
nduced synthesis of TNF  from cancerous cells. TNF  is
elieved to be the central link between RC extract and itsPlease cite this article in press as: Hafidh RR, et al. Novel anticancer activ
f.  rubra. Eur J Integr Med (2013), http://dx.doi.org/10.1016/j.eujim.2013.
emarkable ability to induce cdk-inhibitors and/or downregu-
ate cyclins. A previous report showed that TNF  induces p21
waf1) protein in tumor cells and its binding to CDK2/4 and 6
roteins leading to inhibition of the activity of these complexes.tive Medicine xxx (2013) xxx.e1–xxx.e15 xxx.e13
his inhibition leads the cells to G1 arrest; moreover, p21(waf1)
as found to have an essential role in TNF-induced arrest and
hat the deregulation of cyclin D1 may be one of the mechanisms
o escape physiological signals to restrict tumor growth [57]. In
ddition, Jaruga and Rayford revealed that p27Kip1 induces cas-
ase -dependent and -independent stages of cell death that may
nvolve TNF-signaling through TNF receptors 1 [58]. Besides,
t was shown that TNF  plays a central role in downregulating
yclins A, E and D [59].
The anticancer activities of RC extract were investigated
horoughly in the current study. RC extract showed signifi-
ant anticancer activities against human cervical cancer cells
nd human hepatocarcinoma cells. RC extract revealed selective
nticancer action against HeLa cells while less selectivity of RC
xtract was shown with HepG2 cells. RC extract was found to be
 potent inducer for apoptosis in the treated human cancer cells
ia caspase-dependent, both extrinsic and intrinsic, and caspase-
ndependent pathways. RC extract also induced apoptosis and
ell cycle arrest in human cancer cells via cell-type specific
nteractions. Cdk-inhibitor proteins (p21, p27, and p53) were
he main mechanisms used by RC extract to exert G1 cell cycle
rrest and ultimately the final fate of cells, apoptosis. In addition,
C extract induced synthesis of TNF  from cancerous cells and
NF was most probably linked to the apoptotic and cell cycle
lowing/arresting potential of this extract. Taken together, the
ndings of the current study indicated that RC extract is most
ikely a promising anticancer agent by affecting either known or
ew targets in the anticancer chemotherapy. And, because of the
ide range of anticancer activity of RC extract, its anticancer
ctivity is thought to be driven by more than one component giv-
ng the chance for RC extract to exert strong, multi-mechanism,
nd synergistic anticancer effect.
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